荣昌生物：10月30日召开董事会会议

Group 1 - Rongchang Biopharmaceutical (SH 688331) announced on October 30 that its 29th meeting of the second board of directors will be held on October 30, 2025, to review the proposal for the "2025 Q3 Report" [1] - For the year 2024, the revenue composition of Rongchang Biopharmaceutical is 99.61% from the pharmaceutical manufacturing industry and 0.39% from other businesses [1] - As of the report date, the market capitalization of Rongchang Biopharmaceutical is 50 billion yuan [1]